#What is the current situation of KindlyMD regarding its Nasdaq listing?
KindlyMD is facing a Nasdaq delisting warning because its stock has remained below the $1 mark for 30 consecutive trading days. This warning arises from a recent notice issued by Nasdaq on December 10, which indicates that the company does not meet the minimum bid price requirement set forth by the exchange's listing rules.
The company has a specific timeframe to address this issue. KindlyMD has 180 days until June 8, 2026, to elevate its stock price to at least $1 per share to regain compliance. Until then, its shares will continue to trade on the Nasdaq Global Market. Should the company fail to meet this threshold, it could face either a transfer to the Nasdaq Capital Market or implement other remedial actions, such as a reverse stock split, to rectify the situation and avoid delisting.
#How is KindlyMD responding to the Nasdaq warning?
In light of this delisting risk, KindlyMD is actively monitoring its stock price and exploring various options to maintain its Nasdaq listing and adhere to the relevant regulations. On a somewhat positive note, the stock experienced around a 6% increase following the announcement of the Nasdaq delisting risk.
Interestingly, KindlyMD’s stock last traded above $1 in early October of this year and has since seen a significant decline, dropping about 68% year-to-date. This steep decrease emphasizes the urgency for the company to take effective measures in response to the Nasdaq warning to stabilize its stock and regain compliance with Nasdaq's requirements.